{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:28:50Z","timestamp":1792276130323,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011338","name":"AstraZeneca AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003195","name":"Ministerie van Economische Zaken","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijcard.2021.05.018","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T11:02:14Z","timestamp":1621076534000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome"],"prefix":"10.1016","volume":"336","author":[{"given":"Gladys N.","family":"Janssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorrit S.","family":"Lemkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina W.","family":"van der Hoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten A.H.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Everaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn L.","family":"Brinckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorik R.","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno P.","family":"van der Weerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.F.","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Diletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.05.018_bb0005","first-page":"755","article-title":"Early or late intervention in patients with transient st-segment elevation acute coronary syndrome: subgroup analysis of the elisa-3 trial","volume":"88","author":"Badings","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation","volume":"33","author":"Task Force on the management of STseamiotESoC","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0020","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.amjcard.2016.03.009","article-title":"Comparison of outcome of patients with st-segment elevation myocardial infarction and complete versus incomplete st-resolution before primary percutaneous coronary intervention","volume":"117","author":"Lonborg","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.amjcard.2018.02.029","article-title":"Characteristics, management, and outcome of transient st-elevation versus persistent st-elevation and non-st-elevation myocardial infarction","volume":"121","author":"Blondheim","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/eurheartj\/ehy651","article-title":"Timing of revascularization in patients with transient st-segment elevation myocardial infarction: a randomized clinical trial","volume":"40","author":"Lemkes","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0735-1097(95)00210-U","article-title":"Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage","volume":"26","author":"Haider","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12265-014-9572-6","article-title":"Evaluating the optimal timing of revascularisation in patients with transient st-segment elevation myocardial infarction: rationale and design of the transient trial","volume":"7","author":"Lemkes","year":"2014","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12265-016-9691-3","article-title":"Reducing microvascular dysfunction in revascularized patients with st-elevation myocardial infarction by off-target properties of ticagrelor versus prasugrel. Rationale and design of the reduce-mvi study","volume":"9","author":"Janssens","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.118.035931","article-title":"Evaluation of microvascular injury in revascularized patients with st-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel","volume":"139","author":"van Leeuwen","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0055","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1111\/hae.13543","article-title":"Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment","volume":"24","author":"Pitkanen","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehi606","article-title":"Potential significance of spontaneous and interventional st-changes in patients transferred for primary percutaneous coronary intervention: observations from the st-monitoring in acute myocardial infarction study (the monami study)","volume":"27","author":"Terkelsen","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ahj.2007.12.010","article-title":"Transient st-elevation myocardial infarction: clinical course with intense medical therapy and early invasive approach, and comparison with persistent st-elevation myocardial infarction","volume":"155","author":"Meisel","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198710223171704","article-title":"Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy","volume":"317","author":"Hackett","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0075","first-page":"792","article-title":"Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the erosion study)","volume":"38","author":"Jia","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ehjci\/jes271","article-title":"Final infarct size measured by cardiovascular magnetic resonance in patients with st elevation myocardial infarction predicts long-term clinical outcome: an observational study","volume":"14","author":"Lonborg","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0002-9149(01)02268-8","article-title":"Resolution of st-segment elevation following intravenous administration of nitroglycerin and verapamil","volume":"89","author":"Beltrame","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0090","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/01.CIR.94.9.2072","article-title":"Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction","volume":"94","author":"Haider","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0095","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI108902","article-title":"Generation of the combined prothrombin activation peptide (f1-2) during the clotting of blood and plasma","volume":"60","author":"Aronson","year":"1977","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot-bound thrombin is protected from inhibition by heparin-antithrombin iii but is susceptible to inactivation by antithrombin iii-independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2)","volume":"326","author":"Fuster","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4244\/EIJV10I7A137","article-title":"Assessment of the relation between initial culprit vessel patency in acute st-elevation myocardial infarction and endothelial function","volume":"10","author":"Kandhai-Ragunath","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurheartj\/ehy656","article-title":"Impaired endogenous fibrinolysis in st-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the risk ppci study","volume":"40","author":"Farag","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a Plato substudy","volume":"39","author":"Sumaya","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.05.018_bb0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/09537104.2016.1158402","article-title":"Relative effects of different non-vitamin k antagonist oral anticoagulants on global thrombotic status in atrial fibrillation","volume":"27","author":"Farag","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0130","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11239-014-1075-4","article-title":"Par-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease","volume":"38","author":"Rosser","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2021.05.018_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321008305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321008305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:52:59Z","timestamp":1759092779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321008305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":27,"alternative-id":["S0167527321008305"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.05.018","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}